dependent kinase 1 activity inhibits sister chromatid separation through inhibitory phosphorylation of separase [25] . This modification alone is sufficient to inhibit separase in the absence of securin binding and possibly explains why mammalian cells lacking securin are viable.
In human cells, separase activation at the onset of anaphase does not only coincide with securin destruction and cohesin cleavage but also with the cleavage of separase itself [14] . Separase cleavage occurs at at least two closely spaced sites and separates the conserved C-terminal catalytic domain of separase from the N-terminal portion. The correlation between securin destruction and cohesin and separase cleavage implies that these events may be coregulated, but it is not known how separase cleavage is controlled, which protease cleaves separase, and if separase cleavage is required for its activation or inactivation.
Here, we show that securin degradation activates separase to undergo autocatalytic cleavage that can occur at one of three sites. The resulting separase fragments remain associated with each other. Nevertheless, separase cleavage is not essential for separase activation in vitro. We also provide evidence that securin inhibits separase by blocking access of substrates to the active site of separase and that separase is required for sister chromatid separation in human cells in vivo.
Results

Inhibition of Separase Expression in Human Cells by RNA Interference
To obtain insight into the in vivo function of human separase, we transiently transfected HeLa cells with small interfering RNAs (siRNAs) derived from the human separase cDNA. Separase levels were strongly reduced 18 hr after transfection with either one of two different separase siRNAs, called 1/2 and 3/4, whereas mock transfections or transfection with a reverse siRNA (5/6) had only little effect on separase levels ( Figure 1A ). Two days following transfection, securin levels also decreased (data not shown), but other proteins such as in interphase and contained nuclei that were highly abnormal in size and shape ( Figures 1C and 1F) , whereas control transfected cells showed normal nuclear morpholgy ( Figure 1B) . The nuclei were 1-3 times larger than normal, and they were usually lobed or adopted later stages when many cells were dying. At this early stage, separase levels were greatly reduced but were a rosette-like shape. To analyze if these abnormalities coincided with an increase in ploidy, we analyzed chrostill detectable ( Figure 1A ). Some cells might therefore still have contained sufficient amounts of separase for mosomes in mitotic cells. Three days after transfection, only very few mitotic cells could be observed, but some normal mitotic progression. Consistent with this possibility, we observed some normal metaphase, ana-telomitotic cells could be recovered by the addition of nocodazole for 3 hr, followed by mitotic shake off. Chromophase, and early G1 figures in these preparations (Figures 2A-2C ). However, 62% of all metaphase-like some spreads of these cells showed a wide range of chromosome numbers from near diploid to near octoconfigurations showed highly abnormal morphologies, whereas only 8% of all metaphases from mock-transploid ( Figure 1H ), and this is consistent with the possibility that the increased nuclear size is caused by polyfected cells showed abnormalities. Many figures were seen that resembled metaphase plates in side views ploidization. To test directly if cells with abnormally shaped nuclei contained increased chromosome num-( Figures 2D and 2H ) or polar views ( Figures 2E, 2F , and 2I), but the chromosomes in these plates were arranged bers, we treated cells 3 days after siRNA transfection with calyculin A, a phosphatase inhibitor that induces closer to each other than normal (see Figure 2B for comparison). These chromosome plates often had a premature chromosome condensation (PCC) of interphase nuclei in a wide variety of cell lines [26] . When more disk-like shape and not the ring shape with a central opening that is rather typical for the arrangement of cells were fixed 2 hr after the induction of PCC and spread onto slides, chromosomes could be visualized chromosomes in normal human metaphase plates. We never observed sister chromatid separation in the abbefore nuclear envelopes had broken down. Under these conditions, large lobed nuclei could clearly be seen to normal chromosome plates. Instead, we observed figures in which chromosomes had apparently begun to contain abnormally high chromosome numbers, confirming that these nuclei are polyploid (Figures 1E and decondense without separating sister chromatids (Figure 2I) , and more irregular mitotic figures apparently 1G). The same specimens also contained chromosomes from cells whose nuclear envelope had already broken decondensed without separating sister chromatids (Figures 2J and 2K ). These observations are consistent with down. Also, these figures contained near tetraploid to near octoploid chromosome numbers ( Figure 1I) 
Loss of Separase Expression Induces Polyploidy
Analysis of Separase Activity by Peptide Inhibitors
To understand when separase's active site is accessible, we added the biotinylated amk inhibitors either prior, during, or after activation of separase-securin complexes in mitotic Xenopus extracts. Subsequently, we analyzed inhibitor binding to separase by avidin blotting and separase activity in SCC1 cleavage assays. When biotinylated inhibitor was added to separase-securin complexes before mitotic activation, the cleaved forms of separase that are already present in these immunoprecipitates were clearly detected by avidin blotting, whereas fulllength separase was only labeled very weakly ( Figure  4A , lane 1). This result implies that the active site of fulllength separase is not accessible in separase-securin complexes. When the inhibitor was washed away from these complexes and securin was degraded in mitotic extracts, active separase was recovered, further indicat- the active site of separase can also be accessible to inhibitor, but only once securin is destroyed.
Yet another result was obtained when inhibitor was the ability of peptide inhibitors to bind to either fulllength or cleaved separase could indicate which of these added to separase after it had been activated by securin degradation in mitotic extracts. In this case, most sepaproteins represents an active enzyme.
We synthesized inhibitors based on the hexapeptide rase had been cleaved and only the resulting separase fragments were labeled with inhibitor, whereas residual DREIMR, which represents amino acid residues P6-P1 in the first cleavage site of human SCC1 [13] 
Securin Binding Prevents the Access of Peptides to the Active Site of Separase
We next analyzed if rebinding of securin to activated separase prevents the binding of peptide inhibitors. Activated separase bound an amount of recombinant purified securin that was similar to the amount detected in inactive separase immunoprecipitates, despite the fact that activated separase contained predominantly cleaved separase ( Figure 5A, compare lanes 1 and 4) . This implies that securin can also bind to cleaved separase. The rebinding of securin to separase correlated with the complete loss of separase activity in SCC1 cleavage assays and indicated that securin inhibits separase by direct binding ( Figure 5B) . A destruction box mutant of securin that can not be ubiquitinated by the APC had the same effect, whereas bovine serum albumin (BSA) used as a control did not inhibit separase ( Figure 5B ). During the preparation of this manuscript, Stemmann et al. [25] showed similarly that recombinant securin can inhibit purified separase. We next analyzed if peptide inhibitors can still bind to activated separase once securin has been rebound ( Figure 5C ). We observed that no peptide labeling was obtained if separase was preincubated with securin, whereas preincubation with a recombinant purified cyclin fragment had no effect. Conversely, the binding of inhibitor to separase did not detectably reduce the binding of securin to separase, indicating that securin can bind to separase by contacting residues outside the active site of separase. [1] ). We mutated these sites by exchanging the position of the glutamate HeLa cells. FLAG immunoprecipitates were incubated and the arginine residue with each other, because swapin mitotic Xenopus extracts to allow securin destruction, ping these residues in the SCC1 cleavage sites had and the resulting separase cleavage fragments were abolished cleavage completely [13] . To analyze the analyzed by immunoblotting with FLAG antibodies and cleavability of the mutants, we used an N-terminally with antibodies to the C terminus of separase. Both N-FLAG-tagged version of separase that contains a TEV and C-terminal fragments could clearly be detected in protease recognition site between the tag and the first the immunoprecipitates, indicating that they remain amino acid residue of separase. We coexpressed this bound to each other after cleavage (Figure 6 ). Although form of separase together with securin in HeLa cells, separase is cleaved at at least two sites, only a single isolated it by FLAG immunoprecipitation, activated it in 170-kDa band could be detected in the FLAG immumitotic Xenopus extracts, and eluted it from the antibody noblots. However, it is possible that the 170-kDa band beads by incubation with TEV protease. We then anacontains two N-terminal fragments of slightly different lyzed different separase mutants for the presence of lengths that were not resolved by SDS-PAGE. Transfec-C-terminal cleavage products by immunoblotting and tion of separase without securin confirmed the earlier for their ability to cleave SCC1. We also analyzed the observation [19] that securin is required for the accumu-FLAG immunoprecipitates by immunoblotting with seclation of separase (Figure 6) We also generated mutants in which the putative active site cysteine 2029 was mutated to alanine, and a mutant in which serine 1126 was changed to alanine. Stemmann and colleagues [25] had shown that phosphorylation of serine 1126 inhibits separase. We found that separase S1126A was cleaved to the same degree as wild-type separase and also showed similar SCC1 cleavage activity (see below), suggesting that separase was not subject to inhibitory phosphorylation under our isolation and assay conditions. In contrast, separase C2029A did not yield any cleavage products and was unable to cleave SCC1, and this confirmed that cysteine 2029 is critical for protease activity (Figures 7B and 7C ).
When we tested the different separase mutants in SCC1 cleavage assays, we did not observe obvious differences in their activity, with the exception of separase C2029A , which was inactive ( Figure 7C ). Because limiting amounts of the substrate SCC1 were used in this assay, we performed a dose-response experiment with the same amount of SCC1 and varying amounts of either wild-type separase or the EIMR
-EILR
-ELLR
1535 triple mutant. Also under these conditions, in which separase activity was limiting, no differences between the activities of wild-type and mutant separase could be detected ( Figure 7D ). These results suggest that SCC1 cleavage by separase does not depend on the cleavage of separase. Figure 7A, lane 5) , and the presence of these fragments implies that some ated by the protease separase, which dissolves cohesion between sister chromatids by cleaving cohesin. cleavage of the triple mutant may still occur, albeit at very low levels. We furthermore observed one additional Our work further supports this model by showing that inhibition of separase expression in human cells causes band that was migrating more slowly than the fragment generated by cleavage after the very first site, EIMR 1486 phenotypes in interphase and mitosis that are consistent with an essential role of separase in anaphase. We ob-( Figure 7B, marked by a dot in lane 4) . This band disappeared following treatment of separase samples with served that HeLa cells lacking physiological amounts of separase become polyploid and form unusually large -protein phosphatase, indicating that it might represent a phospho-isoform and not a distinct cleavage product and lobed nuclei, suggesting that they were able to rereplicate their DNA but failed to undergo proper mito-(data not shown). phase. Alternatively, it is possible that loss of separase expression had effects on spindle function, although, We further observed that chromosome spreads from separase knockdown cells contained abnormal metaso far, we have been unable to detect obvious spindle defects by immunofluorescence microscopy (data not phase-like figures. Chromosomes were often arranged in groups that were smaller than normal metaphase shown). Importantly, we observed numerous chromosome figures in which unseparated sister chromatids plates. We presently do not know the molecular cause of this phenotype, but it is conceivable that sister chrohad begun to decondense, suggesting that they were derived from cells that were exiting mitosis without having separated their sister chromatids. We performed our RNA interference experiments in HeLa cells, which are unable to arrest in G1 in the presence of a tetraploid or polyploid DNA content and therefore continue to rereplicate their DNA. If loss of separase expression caused a defect in sister chromatid separation, one would expect to observe chromosomes containing four chromatids (diplochromosomes) in these cells. Such chromosomes have been observed in separase-defective Drosophila mutants [8, 18], whereas separase mutants in other organisms have not been analyzed for the presence of diplochromosomes yet. To our surprise, we have so far been unable to observe diplochromosomes in separase knockdown cells. Low but significant numbers of diplochromosomes have been found in HeLa cells expressing noncleavable cohesin, but, unexpectedly, these showed only some cohesion along chromosome arms and not at centromeres, where sister chromatids are normally tightly held together in metaphase [13] . One possible explanation for these conflicting observations is that separase is required for the timely resolution of sister chromatid cohesion at the onset of anaphase but that sisters can nevertheless be Our finding that peptide inhibitors can bind to the active site of full-length separase only if the inhibitor is true, the securin-induced conformational change had to be reversible because we observed that securin is able present during securin degradation implies that securin proteolysis uncovers the active site of separase that to reinhibit already-activated separase. We further note that caspases, which are distantly related to separase, then rapidly cleaves itself. This cleavage reaction nor-mally occurs at either one of two sites. However, if the Conclusions Our separase siRNA experiments suggest that separase first of these is mutated, a third site further upstream can also be used, as if separase "searches" for a cleavable function is required for sister chromatid separation during mitosis in human cells. Our data are consistent with site nearby if the usual site is changed in its sequence. This implies that both the amino acid sequence around the idea that securin prevents access of substrates to the active site of separase. Upon release of its inhibitor the cleavage site and its position within the protein are important determinants of autocatalytic cleavage.
Separase Cleavage Occurs Autocatalytically
securin, separase cleaves itself at one of three potential sites into fragments that remain noncovalently associated with each other. As separase cleavage is not essenWhy Is Human Separase Cleaved?
tial for its activation in vitro, it is conceivable that sepaActive preparations of separase contain predominantly rase cleavage prepares the enzyme for its subsequent cleaved separase. Only these, and not the residual inactivation. amounts of full-length separase that are also present,
